(Q35925071)

English

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

scientific article published on 23 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study (English)

1 reference

Europe PubMed Central

11 August 2017

multicenter clinical trial

0 references

17

object named as

Rainer Storb

1 reference

Europe PubMed Central

11 August 2017

Keith M. Sullivan

21

object named as

Keith M Sullivan

1 reference

Europe PubMed Central

11 August 2017

Leslie J. Crofford

3

object named as

Leslie J Crofford

1 reference

Europe PubMed Central

11 August 2017

C Fred LeMaistre

10

object named as

C Fred LeMaistre

1 reference

Europe PubMed Central

11 August 2017

Gretchen Henstorf

9

object named as

Gretchen Henstorf

1 reference

Europe PubMed Central

11 August 2017

Theodore A Gooley

7

object named as

Theodore A Gooley

1 reference

Europe PubMed Central

11 August 2017

author name string

Richard A Nash

1

1 reference

Europe PubMed Central

11 August 2017

Peter A McSweeney

2

1 reference

Europe PubMed Central

11 August 2017

Muneer Abidi

4

1 reference

Europe PubMed Central

11 August 2017

Chien-Shing Chen

5

1 reference

Europe PubMed Central

11 August 2017

J David Godwin

6

1 reference

Europe PubMed Central

11 August 2017

Leona Holmberg

8

1 reference

Europe PubMed Central

11 August 2017

Maureen D Mayes

11

1 reference

Europe PubMed Central

11 August 2017

Kevin T McDonagh

12

1 reference

Europe PubMed Central

11 August 2017

Bernadette McLaughlin

13

1 reference

Europe PubMed Central

11 August 2017

Jerry A Molitor

14

1 reference

Europe PubMed Central

11 August 2017

J Lee Nelson

15

1 reference

Europe PubMed Central

11 August 2017

Howard Shulman

16

1 reference

Europe PubMed Central

11 August 2017

Federico Viganego

18

1 reference

Europe PubMed Central

11 August 2017

Mark H Wener

19

1 reference

Europe PubMed Central

11 August 2017

James R Seibold

20

1 reference

Europe PubMed Central

11 August 2017

Daniel E Furst

22

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

23 April 2007

1 reference

Europe PubMed Central

11 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

11 August 2017

110

1 reference

Europe PubMed Central

11 August 2017

4

1 reference

Europe PubMed Central

11 August 2017

1388-1396

1 reference

Europe PubMed Central

11 August 2017

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

Rational therapy in the treatment of systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

2 October 2017

Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

11 July 2018

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

11 July 2018

A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

11 July 2018

Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

11 July 2018

Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

24 September 2018

Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

24 September 2018

The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

24 September 2018

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

24 September 2018

Solid cancers after bone marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1939909

24 September 2018

Skin involvement in scleroderma--where histological and clinical scores meet

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous hematopoietic stem cell transplantation for autoimmune diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologo

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous stem cell transplantation for autoimmune diseases: issues in protocol development

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localized and systemic scleroderma show different histological responses to methotrexate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2007-02-072389

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35925071&oldid=2120097735"